Clinical Trial Update: Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients [EARLY_Phase 1]

View source ↗

Summary

Early-phase, placebo-controlled study to evaluate single and multiple ascending doses of UDP-003 in healthy participants and patients with atherosclerotic cardi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Coronary Syndrome

Drugs mentioned

• UDP-003

Snippet

Sponsor: Cyclarity Therapeutics, Inc. | Conditions: Atherosclerotic Cardiovascular Disease, Acute Coronary Syndromes | EARLY_Phase 1 | Status: RECRUITING